Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation
Authors:
- 1 May 2014
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 447 (3) , 465-470
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31301160, 81071915, 2011KZ107)
- Nanjing Municipal Health Bureau (31301160, 81071915, 2011KZ107)
This publication has 24 references indexed in Scilit:
- Kinesins and cancerNature Reviews Cancer, 2012
- To step or not to step? How biochemistry and mechanics influence processivity in Kinesin and Eg5Current Opinion in Cell Biology, 2007
- The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinksNature, 2005
- Antitumor Activity of a Kinesin InhibitorCancer Research, 2004
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004
- HR22C16: A Potent Small‐Molecule Probe for the Dynamics of Cell DivisionAngewandte Chemie International Edition, 2003
- Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5Journal of Cell Biology, 2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999
- Microtubule dynamics in living cellsCurrent Opinion in Cell Biology, 1998
- The bimC family of kinesins: essential bipolar mitotic motors driving centrosome separationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997